Use of Biotene Moisturizing Mouth Spray for Xerostomia Associated With Oral Oxybutynin Use

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a randomized placebo controlled trial of the use of Biotene versus no treatment in women receiving oral oxybutynin for overactive bladder. The primary outcome will be rate of discontinuation of oxybutynin at 6 month.
Epistemonikos ID: caede6b98c623944b6e9fd921938f5ee49591576
First added on: May 12, 2024